Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Universität des Saarlandes
University of Nebraska
University of Nebraska
Goethe University
Gustave Roussy, Cancer Campus, Grand Paris
Universität des Saarlandes
Universität des Saarlandes
German High-Grade Non-Hodgkin's Lymphoma Study Group
University of Wisconsin, Madison
Royal Marsden NHS Foundation Trust
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Miami
Alliance for Clinical Trials in Oncology
Samsung Medical Center
M.D. Anderson Cancer Center
Swiss Cancer Institute
Case Comprehensive Cancer Center